These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8971427)

  • 1. Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid.
    Böger RH; Bode-Böger SM; Kramme P; Tsikas D; Gutzki FM; Frölich JC
    Br J Clin Pharmacol; 1996 Dec; 42(6):721-7. PubMed ID: 8971427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
    Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
    Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
    J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
    Vesterqvist O
    Eur J Clin Pharmacol; 1986; 30(1):69-73. PubMed ID: 3519239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
    Vainio M; Riutta A; Koivisto AM; Mäenpää J
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypotensive action of captopril and enalapril is not prostacyclin dependent.
    Gerber JG; Franca G; Byyny RL; LoVerde M; Nies AS
    Clin Pharmacol Ther; 1993 Nov; 54(5):523-32. PubMed ID: 8222495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
    Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
    Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Life Sci; 2000 Jul; 67(7):839-46. PubMed ID: 10968413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients.
    Carlsson I; Benthin G; Petersson AS; Wennmalm A
    Thromb Res; 1990 Feb; 57(3):437-44. PubMed ID: 2107595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.
    Minuz P; Barrow SE; Cockcroft JR; Ritter JM
    Br J Clin Pharmacol; 1990 Oct; 30(4):519-26. PubMed ID: 2291866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.
    Wagner B; Eichler HG; Schneider B; Blöchl-Daum B; Brenner B; Gasic S; Lechner K; Kyrle PA
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):453-6. PubMed ID: 1436129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.